Developer docs
API playgroundTry for free, no card

Search company profiles

Erbe Elektromedizin

Full company profile

uuid0007zmf

Namestring
Erbe Elektromedizin
Legal namestring
Erbe Elektromedizin GmbH
Websiteurl
us.erbe-med.com
Company typeenum
Private
Founded yearint
1851
Descriptiontext

Erbe Elektromedizin GmbH is a privately held German medical technology company founded in 1851 in Tübingen by Christian Heinrich Erbe. The company develops, manufactures, and markets energy-based surgical systems used in professional medical settings across multiple surgical disciplines, including electrosurgery, plasmasurgery, hydrosurgery, cryosurgery, and irrigation/insufflation. Its core product platforms include the VIO® 3n electrosurgical generator, FiAPC® plus plasma surgery probes, the HybridKnife® hydrosurgery device for tissue-selective hydrodissection, and the ERBECRYO® 2 cryosurgery system focused on pulmonology applications. Together these platforms form an integrated hardware-and-handpiece architecture in which generators pair with procedure-specific probes and accessories.

The company operates a B2B direct enterprise sales model targeting acute care hospitals, surgical centers, and specialty clinics in more than 19 countries, supported by regional offices including the Erbe USA, Inc. headquarters in Marietta, Georgia. Revenue is generated primarily through capital equipment hardware sales of surgical generators and instruments, complemented by technical service contracts, regulatory maintenance offerings, and clinical education delivered through the Erbe Academy. Customer segmentation is vertical, organized around surgical disciplines such as gastroenterology, pulmonology, and other minimally invasive specialties where precision, reproducibility, and tissue-selective energy delivery are core clinical requirements.

The company is structured as a GmbH (German limited liability company) with wholly-owned regional subsidiaries, has maintained private ownership across its 175-year history, and continues to invest in facility expansion (e.g., the new Erbe USA Logistics & Technical Service Center opened in 2026) and portfolio expansion through bolt-on acquisitions (Maxer Endoscopy, 2021).

Short descriptiontext

Erbe Elektromedizin is a privately held German medical technology company that develops and manufactures energy-based surgical systems—including electrosurgery, plasmasurgery, hydrosurgery, and cryosurgery platforms—for hospitals, surgical centers, and specialty surgeons across more than 19 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersStuttgart, Germany
HQ citystring
Stuttgart
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electrosurgical generators, plasma surgery systems, cryosurgery equipment, hydrosurgery devices, surgical energy instruments
Industry4 codes
1Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
CodeHLAHADACPrimaryYes
2Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
CodeHLAHADABPrimaryNo
3Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
CodeHLAHADAAPrimaryNo
4Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryNo
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Energy Instruments
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of surgical equipment and devices including electrosurgery generators, plasma surgery systems, hydrosurgery instruments, cryosurgery units, and irrigation/insufflation equipment. Primary revenue stream from capital equipment sales to hospitals and surgical centers.

us.erbegroup.com
2Service and Technical Support
TypeProfessional Services
Description

Technical service and customer support offerings including regulatory maintenance requirements and investment protection services

us.erbegroup.com
3Clinical Education and Training
TypeProfessional Services
Description

Continuing education programs through Erbe Academy, including lectures and educational materials for clinical training

us.erbegroup.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1VIO®
Description

Electrosurgical generator platform, with VIO® 3n being the latest evolution featuring advanced upgrades for electrosurgical applications.

us.erbegroup.com
+3 more records
Core offering1 text field

Erbe Elektromedizin develops, manufactures, and markets energy-based surgical systems for professional medical use across five surgical modalities: electrosurgery, plasmasurgery, cryosurgery, hydrosurgery, and irrigation/insufflation. The company sells capital equipment, specialized probes and handpieces, and associated technical service to hospitals, surgical centers, and specialty clinics worldwide. Its product portfolio centers on proprietary platforms such as the VIO 3n electrosurgical generator, FiAPC plus plasma probes, HybridKnife hydrodissection device, and ERBECRYO 2 cryosurgery system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Expanded electrosurgical applications with VIO 3n
+1 more record
Product overview1 text field

Erbe Elektromedizin is a medical technology company offering a modular portfolio of energy-based surgical systems. The core offerings span five surgical specialties: Electrosurgery (featuring the VIO® 3n platform), Plasmasurgery (FiAPC® plus probes), Hydrosurgery (HybridKnife®), Cryosurgery (ERBECRYO® 2), and Irrigation & Insufflation. The VIO® 3n represents the latest generation electrosurgical generator platform, which serves as a foundation for various surgical applications, while specialized handpieces and probes (FiAPC® plus, HybridKnife®, ERBECRYO® 2) provide tissue-specific treatment modalities across different procedures.

Product and service6 records
1VIO 3n
CategoryElectrosurgery
Description

Advanced electrosurgical generator platform providing cutting, coagulation, and tissue modification capabilities with enhanced precision and control for expanding electrosurgical applications across surgical disciplines.

2FiAPC plus
CategoryPlasmasurgery
Description

Plasmasurgery probe system providing control, consistency, reliability, and reproducibility in argon plasma coagulation (APC) therapy for various electrosurgical applications.

3HybridKnife
CategoryHydrosurgery
Description

Hydrosurgery device for high-pressure tissue-selective hydrodissection, combining irrigation and dissection capabilities in a single instrument.

4ERBECRYO 2
CategoryCryosurgery
Description

Flexible cryosurgery system for pulmonology applications including cryoextraction and cryodevitalization, designed to deliver reproducible cryotherapy treatments.

5Erbe Service and Technical Support
CategoryService and Support
Description

Technical service and customer support programs including regulatory maintenance and investment protection for Erbe medical devices purchased by hospitals and surgical centers.

6Erbe Academy Clinical Education
CategoryClinical Education and Training
Description

Continuing medical education programs providing lectures, booklets, and workshops for medical professionals using Erbe surgical systems.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Stryker's Surgical Technologies and Endoscopy businesses compete with Erbe in electrosurgery, ENT/bronchoscopy procedures (relevant to ERBECRYO® 2), and integrated OR/visualization solutions following Erbe's Maxer Endoscopy acquisition.

TypeDirect peer
Description

Olympus is a direct competitor in GI endoscopy and pulmonary endoscopy, where Erbe's ERBECRYO® 2 cryotherapy and HybridKnife® are used; Olympus also sells its own electrosurgical and argon plasma coagulation devices, overlapping with VIO® and FiAPC®.

TypeEmerging player
Description

Apyx Medical (formerly Bovie Medical) is a smaller competitor in electrosurgical and helium-based plasma/Renuvion platforms, overlapping with Erbe's FiAPC® and VIO® portfolios in select surgical and aesthetic segments.

TypeDirect peer
Description

CONMED is a focused direct competitor in electrosurgical generators, smoke evacuation, and advanced energy devices, serving the same hospital and ASC customer base as Erbe with overlapping product lines.

TypeBroad incumbent
Description

Medtronic's Surgical Innovations business (inheriting Covidien energy products) competes with Erbe in electrosurgical generators, vessel sealing, and advanced energy instruments sold to the same acute-care hospital and surgical center customers.

TypeBroad incumbent
Description

Smith+Nephew's Advanced Wound Management and Sports Medicine/ENT businesses overlap with Erbe in electrosurgical generators and ablation devices for ENT/pulmonology and wound applications.

TypeDirect peer
Description

BOWA is a German-based, privately held competitor focused on electrosurgery and vessel sealing, directly competing with Erbe's VIO® platform in European hospitals and specialty surgical centers.

TypeDirect peer
Description

KLS Martin is a German mid-cap surgical device company offering electrosurgery, HF generators, and surgical instruments — directly comparable to Erbe in specialty surgery (ENT, CMF, plastic surgery) with similar mid-sized, family-influenced private company profile.

TypeBroad incumbent
Description

Boston Scientific's Endoscopy and Urology/Pelvic Health divisions compete with Erbe's GI and interventional pulmonology products (especially ERBECRYO® 2 and HybridKnife®) and offer comparable capital-plus-consumables commercial models.

TypeBroad incumbent
Description

Ethicon, J&J's surgical devices arm, is the largest global player in energy-based surgical instruments (electrosurgery, ultrasonic, advanced bipolar) and directly competes with Erbe's VIO® electrosurgery and FiAPC® platforms across the same hospital customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Erbe Elektromedizin

Surgical Energy Instrumentsus.erbe-med.com

Erbe Elektromedizin is a privately held German medical technology company that develops and manufactures energy-based surgical systems—including electrosurgery, plasmasurgery, hydrosurgery, and cryosurgery platforms—for hospitals, surgical centers, and specialty surgeons across more than 19 countries.

What Erbe Elektromedizin does

Erbe Elektromedizin GmbH is a privately held German medical technology company founded in 1851 in Tübingen by Christian Heinrich Erbe. The company develops, manufactures, and markets energy-based surgical systems used in professional medical settings across multiple surgical disciplines, including electrosurgery, plasmasurgery, hydrosurgery, cryosurgery, and irrigation/insufflation. Its core product platforms include the VIO® 3n electrosurgical generator, FiAPC® plus plasma surgery probes, the HybridKnife® hydrosurgery device for tissue-selective hydrodissection, and the ERBECRYO® 2 cryosurgery system focused on pulmonology applications. Together these platforms form an integrated hardware-and-handpiece architecture in which generators pair with procedure-specific probes and accessories.

The company operates a B2B direct enterprise sales model targeting acute care hospitals, surgical centers, and specialty clinics in more than 19 countries, supported by regional offices including the Erbe USA, Inc. headquarters in Marietta, Georgia. Revenue is generated primarily through capital equipment hardware sales of surgical generators and instruments, complemented by technical service contracts, regulatory maintenance offerings, and clinical education delivered through the Erbe Academy. Customer segmentation is vertical, organized around surgical disciplines such as gastroenterology, pulmonology, and other minimally invasive specialties where precision, reproducibility, and tissue-selective energy delivery are core clinical requirements.

The company is structured as a GmbH (German limited liability company) with wholly-owned regional subsidiaries, has maintained private ownership across its 175-year history, and continues to invest in facility expansion (e.g., the new Erbe USA Logistics & Technical Service Center opened in 2026) and portfolio expansion through bolt-on acquisitions (Maxer Endoscopy, 2021).

Erbe Elektromedizin firmographics

Firmographics
Name
Erbe Elektromedizin
Legal name
Erbe Elektromedizin GmbH
Website
https://us.erbe-med.com
Company type
Private
Founded year
1851
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Erbe Elektromedizin is a privately held German medical technology company that develops and manufactures energy-based surgical systems—including electrosurgery, plasmasurgery, hydrosurgery, and cryosurgery platforms—for hospitals, surgical centers, and specialty surgeons across more than 19 countries.
Ownership category
akta.pro rank

Erbe Elektromedizin industry classification

Industry
Product category
Surgical Energy Instruments
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
akta.pro secondary industries
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

  • Electrosurgical generators
  • Plasma surgery systems
  • Cryosurgery equipment
  • Hydrosurgery devices
  • Surgical energy instruments

Where Erbe Elektromedizin is headquartered

Location

Headquarters

HQ city
Stuttgart
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Erbe Elektromedizin business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Device Hardware Sales: Sale of surgical equipment and devices including electrosurgery generators, plasma surgery systems, hydrosurgery instruments, cryosurgery units, and irrigation/insufflation equipment. Primary revenue stream from capital equipment sales to hospitals and surgical centers.
  2. Service and Technical Support: Technical service and customer support offerings including regulatory maintenance requirements and investment protection services
  3. Clinical Education and Training: Continuing education programs through Erbe Academy, including lectures and educational materials for clinical training

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Erbe Elektromedizin product offering

Product offering

Core offering

Erbe Elektromedizin develops, manufactures, and markets energy-based surgical systems for professional medical use across five surgical modalities: electrosurgery, plasmasurgery, cryosurgery, hydrosurgery, and irrigation/insufflation. The company sells capital equipment, specialized probes and handpieces, and associated technical service to hospitals, surgical centers, and specialty clinics worldwide. Its product portfolio centers on proprietary platforms such as the VIO 3n electrosurgical generator, FiAPC plus plasma probes, HybridKnife hydrodissection device, and ERBECRYO 2 cryosurgery system.

Product overview

Erbe Elektromedizin is a medical technology company offering a modular portfolio of energy-based surgical systems. The core offerings span five surgical specialties: Electrosurgery (featuring the VIO® 3n platform), Plasmasurgery (FiAPC® plus probes), Hydrosurgery (HybridKnife®), Cryosurgery (ERBECRYO® 2), and Irrigation & Insufflation. The VIO® 3n represents the latest generation electrosurgical generator platform, which serves as a foundation for various surgical applications, while specialized handpieces and probes (FiAPC® plus, HybridKnife®, ERBECRYO® 2) provide tissue-specific treatment modalities across different procedures.

Differentiator

Problem solved

Functional benefit

Brands

  • VIO®: Electrosurgical generator platform, with VIO® 3n being the latest evolution featuring advanced upgrades for electrosurgical applications.
  • FiAPC®
  • HybridKnife®
  • ERBECRYO® 2

Products and services

  • VIO 3n Advanced electrosurgical generator platform providing cutting, coagulation, and tissue modification capabilities with enhanced precision and control for expanding electrosurgical applications across surgical disciplines.
  • FiAPC plus Plasmasurgery probe system providing control, consistency, reliability, and reproducibility in argon plasma coagulation (APC) therapy for various electrosurgical applications.
  • HybridKnife Hydrosurgery device for high-pressure tissue-selective hydrodissection, combining irrigation and dissection capabilities in a single instrument.
  • ERBECRYO 2 Flexible cryosurgery system for pulmonology applications including cryoextraction and cryodevitalization, designed to deliver reproducible cryotherapy treatments.
  • Erbe Service and Technical Support Technical service and customer support programs including regulatory maintenance and investment protection for Erbe medical devices purchased by hospitals and surgical centers.
  • Erbe Academy Clinical Education Continuing medical education programs providing lectures, booklets, and workshops for medical professionals using Erbe surgical systems.

Quantifiable outcome

  • Expanded electrosurgical applications with VIO 3n
  • +1 more outcomes

Companies that use Erbe Elektromedizin

Customer profile

Segments2 records

Ideal customer profiles1 record

Erbe Elektromedizin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Erbe Elektromedizin partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Erbe Elektromedizin competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Stryker's Surgical Technologies and Endoscopy businesses compete with Erbe in electrosurgery, ENT/bronchoscopy procedures (relevant to ERBECRYO® 2), and integrated OR/visualization solutions following Erbe's Maxer Endoscopy acquisition.
  • Medtronic: Medtronic's Surgical Innovations business (inheriting Covidien energy products) competes with Erbe in electrosurgical generators, vessel sealing, and advanced energy instruments sold to the same acute-care hospital and surgical center customers.
  • Smith+Nephew: Smith+Nephew's Advanced Wound Management and Sports Medicine/ENT businesses overlap with Erbe in electrosurgical generators and ablation devices for ENT/pulmonology and wound applications.
  • Boston Scientific: Boston Scientific's Endoscopy and Urology/Pelvic Health divisions compete with Erbe's GI and interventional pulmonology products (especially ERBECRYO® 2 and HybridKnife®) and offer comparable capital-plus-consumables commercial models.
  • Johnson & Johnson (Ethicon): Ethicon, J&J's surgical devices arm, is the largest global player in energy-based surgical instruments (electrosurgery, ultrasonic, advanced bipolar) and directly competes with Erbe's VIO® electrosurgery and FiAPC® platforms across the same hospital customer base.

Direct peers

  • Olympus: Olympus is a direct competitor in GI endoscopy and pulmonary endoscopy, where Erbe's ERBECRYO® 2 cryotherapy and HybridKnife® are used; Olympus also sells its own electrosurgical and argon plasma coagulation devices, overlapping with VIO® and FiAPC®.
  • CONMED: CONMED is a focused direct competitor in electrosurgical generators, smoke evacuation, and advanced energy devices, serving the same hospital and ASC customer base as Erbe with overlapping product lines.
  • BOWA-electronic: BOWA is a German-based, privately held competitor focused on electrosurgery and vessel sealing, directly competing with Erbe's VIO® platform in European hospitals and specialty surgical centers.
  • KLS Martin: KLS Martin is a German mid-cap surgical device company offering electrosurgery, HF generators, and surgical instruments — directly comparable to Erbe in specialty surgery (ENT, CMF, plastic surgery) with similar mid-sized, family-influenced private company profile.

Emerging players

  • Apyx Medical: Apyx Medical (formerly Bovie Medical) is a smaller competitor in electrosurgical and helium-based plasma/Renuvion platforms, overlapping with Erbe's FiAPC® and VIO® portfolios in select surgical and aesthetic segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Erbe Elektromedizin social profiles

Digital presence

Erbe Elektromedizin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Erbe Elektromedizin leadership team

Management profile

Number of profiles

Profiles1 record

Erbe Elektromedizin subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Erbe Elektromedizin funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Erbe Elektromedizin M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Erbe Elektromedizin

What does Erbe Elektromedizin do?

Erbe Elektromedizin develops, manufactures, and markets energy-based surgical systems for professional medical use across five surgical modalities: electrosurgery, plasmasurgery, cryosurgery, hydrosurgery, and irrigation/insufflation. The company sells capital equipment, specialized probes and handpieces, and associated technical service to hospitals, surgical centers, and specialty clinics worldwide. Its product portfolio centers on proprietary platforms such as the VIO 3n electrosurgical generator, FiAPC plus plasma probes, HybridKnife hydrodissection device, and ERBECRYO 2 cryosurgery system.

Is Erbe Elektromedizin a public or private company?

Erbe Elektromedizin is a private company. It is classified as family owned and is currently operating.

When was Erbe Elektromedizin founded?

Erbe Elektromedizin was founded in 1851. It employs 1,001 to 5,000 people.

Where is Erbe Elektromedizin based?

Erbe Elektromedizin is headquartered in Stuttgart, Germany, in the Europe region.

How does Erbe Elektromedizin make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are service and Technical Support and clinical Education and Training.

Who are Erbe Elektromedizin's main competitors?

Broad incumbents on record are Stryker, Medtronic, Smith+Nephew, Boston Scientific and Johnson & Johnson (Ethicon). Direct peers are Olympus, CONMED, BOWA-electronic and KLS Martin. Apyx Medical is listed as an emerging player.

Does Erbe Elektromedizin have an API?

No public API is recorded for Erbe Elektromedizin.

What industry is Erbe Elektromedizin in?

Erbe Elektromedizin's product category is Surgical Energy Instruments. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogMOVIVA® launch spotlight at ESGE Days 2026Erbe Elektromedizin will spotlight MOVIVA, a gastric mucosal ablation device for obesity therapy, at ESGE Days 2026 in Milan. Early studies show 7.7% total body weight loss after 6 months, and up to 24% after 12 months when combined with endoscopic sleeve gastroplasty. The device is available in CE and CE-related markets.openPR.comSpray Cryotherapy System Market Is Booming Rapidly with Strong Demand By 2033 | Brymill Cryogenic Systems, CryoConcepts, Erbe ElektromedizinCoherent Market Insights published a market research report on the global Spray Cryotherapy System Market covering the period 2026-2033, examining market trends, segmentation by product type and application, and competitive dynamics across key industry players.NDTV ProfitGraphic User Interfaces Now Registrable As Designs In India: Landmark Ruling By Calcutta High CourtThe Calcutta High Court delivered a landmark ruling on March 9 holding that graphic user interfaces (GUIs) satisfy the criteria of a 'design' under the Designs Act, 2000, making them eligible for registration in India. The court set aside five orders from the Controller of Patents and Designs that had rejected GUI registration applications from NEC Corporation, Erbe Elektromedizin GmbH, Abiomed Inc, and TVS Motor Co., finding that the Controller had applied incorrect legal tests and that GUIs reflect creative choices in arrangement, proportion, spacing, color palette, and icon design. The ruling aligns India with the 92% of global jurisdictions that already protect GUIs under design laws and calls for modernization of India's design protection regime through legislative amendment or clarificatory guidance.openPR.comKey Factors and Emerging Trends Shaping the Bipolar Electrosurgical Devices Market EnvironmentThe bipolar electrosurgical devices market is projected to grow to $9.19 billion by 2030, reflecting a 9.8% compound annual growth rate, driven by increasing demand for minimally invasive procedures, rising chronic disease prevalence, and stricter surgical safety regulations. UK-based Halma plc acquired France's Lamidey Noury Medical in November 2024 to expand its minimally invasive surgical product portfolio, while Germany-based Erbe Elektromedizin GmbH launched its VIO seal platform in April 2025, a digital bipolar energy system for vessel sealing and dissection. The market features several prominent players including Johnson & Johnson, Medtronic, Stryker, and Boston Scientific, with digital integration and connected energy management platforms emerging as key innovation trends.Business Wire BlogGMA with MOVIVA®: setting new standards in endoscopic bariatric treatmentErbe Elektromedizin reports that its MOVIVA® device for Gastric Mucosal Ablation (GMA) has been used in approximately 80 procedures across eight European countries within months of the first clinical case at Policlinico Universitario Agostino Gemelli in Rome. The device combines needle-free injection with argon plasma coagulation to target the gastric fundus and reduce ghrelin production, offering a less invasive alternative to traditional bariatric surgery. Erbe plans a commercial launch of MOVIVA® in 2026, with the product currently available in CE and CE-related markets.ConallianceConAlliance Advises Erbe Elektromedizin on the Acquisition of Maxer EndoscopyConAlliance advised and supported Erbe Elektromedizin in its acquisition of Maxer Endoscopy, handling strategy, due diligence and contract negotiations. Erbe's CEO Christian O. Erbe said the fluorescence imaging systems complement its energy-emitting products, while Maxer's CEO Shirish Joshi said the deal will accelerate image-guided surgery innovations. Erbe's sales force and partners will distribute the instruments to over 110 countries.Healthcare business newsNew surgical procedure for effective thermofusion and dissection of vesselsErbe Elektromedizin has agreed to become the exclusive distributor in Europe for SurgRx's EnSeal product, which integrates with Erbe's VIO 300D electrosurgical system. This partnership allows SurgRx to retain manufacturing rights while leveraging Erbe's distribution network, with sales activities scheduled to begin in December 2006. The combined technology aims to improve vessel-sealing quality and surgical safety through advanced tissue thermofusion capabilities.